Izadora Demmer
Pathologie · Dept. IV
Prolonged Response to Afatinib and Crizotinib in a Rare Case of -, -, - and -Alterated Lung Adenocarcinoma.
Plomer E, Früh M, Lauber A, Demmer I, Jochum W, Koster K. Prolonged Response to Afatinib and Crizotinib in a Rare Case of -, -, - and -Alterated Lung Adenocarcinoma. Int J Mol Sci 2024; 25
23.05.2024Prolonged Response to Afatinib and Crizotinib in a Rare Case of -, -, - and -Alterated Lung Adenocarcinoma.
23.05.2024Int J Mol Sci 2024; 25
Plomer Eva, Früh Martin, Lauber Arno, Demmer Izadora, Jochum Wolfram, Koster Kira-Lee
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Koster K, Messerich N, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W, Rao T, Silzle T. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers (Basel) 2023; 15
24.09.2023Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
24.09.2023Cancers (Basel) 2023; 15
Koster Kira-Lee, Messerich Nora-Medea, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Graf Lukas, Holbro Andreas, Benz Rudolf, Demmer Izadora, Jochum Wolfram, Rao Tata Nageswara, Silzle Tobias
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Messerich N, Uda N, Volken T, Cogliatti S, Lehmann T, Holbro A, Benz R, Graf L, Gupta V, Jochum W, Demmer I, Rao T, Silzle T. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers (Basel) 2023; 15
25.02.2023CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
25.02.2023Cancers (Basel) 2023; 15
Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobias
Distinct microbial communities colonize tonsillar squamous cell carcinoma.
De Martin A, Lütge M, Stanossek Y, Engetschwiler C, Cupovic J, Brown K, Demmer I, Broglie M, Geuking M, Jochum W, McCoy K, Stöckli S, Ludewig B. Distinct microbial communities colonize tonsillar squamous cell carcinoma. Oncoimmunology 2021; 10:1945202.
25.07.2021Distinct microbial communities colonize tonsillar squamous cell carcinoma.
25.07.2021Oncoimmunology 2021; 10:1945202
De Martin Angelina, Lütge Mechthild, Stanossek Yves, Engetschwiler Céline, Cupovic Jovana, Brown Kirsty, Demmer Izadora, Broglie Martina Anja, Geuking Markus B, Jochum Wolfram, McCoy Kathy D, Stöckli Sandro, Ludewig Burkhard
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
Schmid S, Jochum W, Addeo A, Demmer I, Schär S, Janthur W, Wannesson L, König D, Britschgi C, Frösch P, Bouchaab H, Rothschild S, Blum V, Friedlaender A, Mauti L, Früh M. Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort. Cancer Immunol Immunother 2020; 69:1605-1613.
19.04.2020Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
19.04.2020Cancer Immunol Immunother 2020; 69:1605-1613
Schmid Sabine, Jochum Wolfram, Addeo Alfredo, Demmer Izadora, Schär Sämi, Janthur Wolf-Dieter, Wannesson Luciano, König David, Britschgi Christian, Frösch Patrizia, Bouchaab Hasna, Rothschild Sacha I, Blum Veronika, Friedlaender Alex, Mauti Laetitia A, Früh Martin